Updated Results of a Randomized Phase II Trial of Idarubicin and Cytarabine with Clofarabine or Fludarabine in Patients with Newly Diagnosed Acute Myeloid Leukemia

被引：0
|
作者：
Short, Nicholas J. [1 ]
Ravandi, Farhad [2 ]
Huang, Xuelin [3 ]
Cortes, Jorge E. [2 ]
Pemmaraju, Naveen [2 ]
Daver, Naval [2 ]
Khouri, Rita B. [2 ]
Borthakur, Gautam [2 ]
Jain, Nitin [2 ]
Konopleva, Marina [2 ]
Estrov, Zeev [2 ]
Garcia-Manero, Guillermo [2 ]
Kadia, Tapan M. [2 ]
Wierda, William G. [2 ]
DiNardo, Courtney D. [2 ]
O'Brien, Susan M. [2 ]
Shah, Syed [2 ]
Pike, Allison [2 ]
Brandt, Mark [2 ]
Kantarjian, Hagop M. [2 ]
Jabbour, Elias J. [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostatist, Houston, TX USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.1067.1067
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1067
引用
收藏
页数：7
相关论文
共 50 条
  • [1] Idarubicin and cytarabine with clofarabine or fludarabine in adults with newly diagnosed acute myeloid leukemia: Updated results of a randomized phase II study.
    Issa, Ghayas C.
    Kantarjian, Hagop M.
    Short, Nicholas James
    Ravandi, Farhad
    Huang, Xuelin
    Garcia-Manero, Guillermo
    Plunkett, William
    Gandhi, Varsha
    Pemmaraju, Naveen
    Daver, Naval Guastad
    Borthakur, Gautam
    Jain, Nitin
    Konopleva, Marina
    Estrov, Zeev
    Kadia, Tapan M.
    Dinardo, Courtney Denton
    Brandt, Mark
    O'Brien, Susan Mary
    Cortes, Jorge E.
    Jabbour, Elias
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] A Randomized Phase 2 Study of Idarubicin and Cytarabine With Clofarabine or Fludarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia
    Jabbour, Elias
    Short, Nicholas J.
    Ravandi, Farhad
    Huang, Xuelin
    Xiao, Lianchun
    Garcia-Manero, Guillermo
    Plunkett, William
    Gandhi, Varsha
    Sasaki, Koji
    Pemmaraju, Naveen
    Daver, Naval G.
    Borthakur, Gautam
    Jain, Nitin
    Konopleva, Marina
    Estrov, Zeev
    Kadia, Tapan M.
    Wierda, William G.
    DiNardo, Courtney D.
    Brandt, Mark
    O'Brien, Susan M.
    Cortes, Jorge E.
    Kantarjian, Hagop
    CANCER, 2017, 123 (22) : 4430 - 4439
  • [3] A RANDOMIZED PHASE II STUDY OF IDARUBICIN AND CYTARABINE WITH EITHER CLOFARABINE OR FLUDARABINE IN ADULTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
    Short, N.
    Kantarjian, H.
    Ravandi, F.
    Huang, X.
    Xiao, L.
    Garcia-Manero, G.
    Plunkett, W.
    Gandhi, V.
    Sasaki, K.
    Pemmaraju, N.
    Daver, N.
    Borthakur, G.
    Jain, N.
    Konopleva, M.
    Estrov, Z.
    Kadia, T.
    Wierda, W.
    DiNardo, C.
    Brandt, M.
    O'Brien, S.
    Cortes, J.
    Jabbour, E.
    HAEMATOLOGICA, 2017, 102 : 53 - 53
  • [4] Idarubicin and Cytarabine Combined with Clofarabine or Fludarabine for the Treatment of Newly Diagnosed Acute Myeloid Leukemia: Interim Result of a Phase II Clinical Trial
    Koller, Paul B.
    Sasaki, Koji
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    O'Brien, Susan
    Cortes, Jorge E.
    Kadia, Tapan
    Borthakur, Gautam
    Pemmaraju, Naveen
    Daver, Naval
    Chahoud, Jad
    Pike, Allison
    Brandt, Mark
    Pierce, Sherry
    Kantarjian, Hagop M.
    Jabbour, Elias
    BLOOD, 2015, 126 (23)
  • [5] Interim results of a phase I/II randomized study of clofarabine, idarubicin, and cytarabine (CIA) versus fludarabine, idarubicin, and cytarabine (FIA) for newly diagnosed or relapsed patients (pts) with acute myeloid leukemia (AML).
    Mathisen, Michael
    Kantarjian, Hagop
    Faderl, Stefan
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Kadia, Tapan M.
    Daver, Naval Guastad
    O'Brien, Susan Mary
    Dorkhom, Stephan Joseph
    Pierce, Sherry
    Lira, Cynthia
    Cortes, Jorge E.
    Jabbour, Elias
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Updated Results of a Phase I/II, Randomized Study of Clofarabine Combined with Idarubicin and Cytarabine (CIA) or Fludarabine Combined with Idarubicin and Cytarabine (FIA) for the Treatment of Patients (pts) with Newly Diagnosed or Relapsed/Refractory (RR) Acute Myeloid Leukemia (AML)
    Mathisen, Michael S.
    Kantarjian, Hagop M.
    Ravandi, Farhad
    Pemmaraju, Naveen
    Garcia-Manero, Guillermo
    Cortes, Jorge E.
    O'Brien, Susan
    Quintas-Cardama, Alfonso
    Ghanem, Hady
    Daver, Naval G.
    Pierce, Sherry A.
    Lira, Cynthia
    Faderl, Stefan
    Jabbour, Elias
    BLOOD, 2012, 120 (21)
  • [7] A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia
    Short, Nicholas J.
    Kantarjian, Hagop
    Ravandi, Farhad
    Huang, Xuelin
    Xiao, Lianchun
    Garcia-Manero, Guillermo
    Plunkett, William
    Gandhi, Varsha
    Sasaki, Koji
    Pemmaraju, Naveen
    Daver, Naval G.
    Borthakur, Gautam
    Jain, Nitin
    Konopleva, Marina
    Estrov, Zeev
    Kadia, Tapan M.
    Wierda, William G.
    DiNardo, Courtney D.
    Brandt, Mark
    O'Brien, Susan M.
    Cortes, Jorge E.
    Jabbour, Elias
    LEUKEMIA & LYMPHOMA, 2018, 59 (04) : 813 - 820
  • [8] Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia
    Nazha, Aziz
    Kantarjian, Hagop
    Ravandi, Farhad
    Huang, Xuelin
    Choi, Sangbum
    Garcia-Manero, Guillermo
    Jabbour, Elias
    Borthakur, Gautam
    Kadia, Tapan
    Konopleva, Marina
    Cortes, Jorge
    Ferrajoli, Alessandra
    Kornblau, Steve
    Daver, Naval
    Pemmaraju, Naveen
    Andreeff, Michael
    Estrov, Zeev
    Du, Min
    Brandt, Mark
    Faderl, Stefan
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (11) : 961 - 966
  • [9] Phase II Trial of Vorinostat With Idarubicin and Cytarabine for Patients With Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome
    Garcia-Manero, Guillermo
    Tambaro, Francesco Paolo
    Bekele, Nebiyou B.
    Yang, Hui
    Ravandi, Farhad
    Jabbour, Elias
    Borthakur, Gautam
    Kadia, Tapan M.
    Konopleva, Marina Y.
    Faderl, Stefan
    Cortes, Jorge E.
    Brandt, Mark
    Hu, Yumin
    Mccue, Deborah
    Newsome, Willie Mae
    Pierce, Sherry R.
    de Lima, Marcos
    Kantarjian, Hagop M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (18) : 2204 - 2210
  • [10] Clofarabine, Idarubicin, and Cytarabine (CIA) As Frontline Therapy for Patients <=60 Years with Newly Diagnosed Acute Myeloid Leukemia (AML)
    Nazha, Aziz
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Huang, Xuelin
    Choi, Sangbum
    Garcia-Manero, Guillermo
    Jabbour, Elias J.
    Borthakur, Gautam
    Kadia, Tapan M.
    Konopleva, Marina
    Cortes, Jorge E.
    Ferrajoli, Alessandra
    Kornblau, Steven M.
    Andreeff, Michael
    Estrov, Zeev
    Daver, Naval G.
    Pemmaraju, Naveen
    Du, Mm
    Brandt, Mark
    Faderl, Stefan
    BLOOD, 2012, 120 (21)
12345